683 Capital Management, LLC Red Hill Biopharma Ltd. Transaction History

683 Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$3.51 - $6.17 $3.63 Million - $6.38 Million	-1,034,650 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.76 - $7.35 $14.1 Million - $17.9 Million	-2,441,389 Reduced 70.23%	1,034,650 $6.28 Million
Q3 2019 Nov 14, 2019	SELL	$6.46 - $8.37 $1.41 Million - $1.82 Million	-217,801 Reduced 5.9%	3,476,039 $24.5 Million
Q4 2018 Feb 14, 2019	BUY	$5.18 - $9.35 $325,412 - $587,376	62,821 Added 1.73%	3,693,840 $20.5 Million
Q3 2018 Nov 14, 2018	BUY	$6.0 - $11.35 $9.53 Million - $18 Million	1,588,365 Added 77.76%	3,631,019 $32.1 Million
Q2 2018 Aug 14, 2018	BUY	$4.82 - $8.53 $1.83 Million - $3.23 Million	378,751 Added 22.76%	2,042,654 $17.4 Million
Q1 2018 May 15, 2018	BUY	$4.96 - $6.84 $3.3 Million - $4.55 Million	664,671 Added 66.52%	1,663,903 $8.57 Million
Q4 2017 Feb 14, 2018	BUY	$4.58 - $10.81 $4.58 Million - $10.8 Million	999,232	999,232 $5.14 Million

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $304M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on 683 Capital Management, LLC with notifications on news.